Journal of Contemporary Brachytherapy

 
2/2026 vol. 18
article image

Editorial

J Contemp Brachytherapy 2026; 18, 2

View text
Magnetic resonance imaging-guided salvage high-dose-rate brachytherapy for local recurrence after prostatectomy and external beam radiotherapy

Original paper

J Contemp Brachytherapy 2026; 18, 2: 117–123

DOI: https://doi.org/10.5114/jcb.2026.162242
Abstract View text (PDF)
Efficacy of peri-operative high-dose-rate interstitial brachytherapy in keloids: Can we scare the bad scar?

Original paper

J Contemp Brachytherapy 2026; 18, 2: 124–130

DOI: https://doi.org/10.5114/jcb.2026.161350
Abstract View text (PDF)
Ruthenium-106 ocular surface brachytherapy for incompletely excised conjunctival melanoma and squamous cell carcinoma

Original paper

J Contemp Brachytherapy 2026; 18, 2: 131–137

DOI: https://doi.org/10.5114/jcb.2026.162466
Abstract View text (PDF)
Fractionated stereotactic re-irradiation after plaque radiotherapy (brachytherapy) failure in uveal melanoma

Original paper

J Contemp Brachytherapy 2026; 18, 2: 138–141

DOI: https://doi.org/10.5114/jcb.2026.161861
Abstract View text (PDF)
The value of pre-brachytherapy MRI in aiding applicator selection for cervical cancer procedures

Original paper

J Contemp Brachytherapy 2026; 18, 2: 142–146

DOI: https://doi.org/10.5114/jcb.2026.163306
Abstract View text (PDF)
Outcomes of cervical carcinoma patients treated with chemoradiation and single-application two-fractions schedule of high-dose-rate brachytherapy: A retrospective review (SATF study)

Original paper

J Contemp Brachytherapy 2026; 18, 2: 154–162

DOI: https://doi.org/10.5114/jcb.2026.163310
Abstract View text (PDF)
Automated planning in image-guided adaptive brachytherapy for cervical cancer: Impact analysis on patient workflows in high-volume centers

Original paper

J Contemp Brachytherapy 2026; 18, 2: 163–170

DOI: https://doi.org/10.5114/jcb.2026.163311
Abstract View text (PDF)
Can image-guided external beam radiotherapy boost be an alternative when intracavitary brachytherapy is unavailable for locally advanced cervical cancer? A dosimetric analysis and literature review

Original paper

J Contemp Brachytherapy 2026; 18, 2: 171–178

DOI: https://doi.org/10.5114/jcb.2026.163312
Abstract View text (PDF)
Iridium-192 high-dose-rate calibration discrepancies: A growing concern?

Original paper

J Contemp Brachytherapy 2026; 18, 2: 179–186

DOI: https://doi.org/10.5114/jcb.2026.163313
Abstract View text (PDF)
Development of a patient-specific adaptive ring for organ at risk contours in high-dose-rate brachytherapy gynecologic cancers

Original paper

J Contemp Brachytherapy 2026; 18, 2: 187–195

DOI: https://doi.org/10.5114/jcb.2026.162464
Abstract View text (PDF)
Automated EQD2 reporting for cervical cancer high-dose-rate brachytherapy using a standalone ESAPI-based application

Original paper

J Contemp Brachytherapy 2026; 18, 2: 196–203

DOI: https://doi.org/10.5114/jcb.2026.162294
Abstract View text (PDF)
Hybrid adjuvant therapy with 3D-printed orbital brachytherapy and stereotactic body radiotherapy for recurrent adenoid cystic carcinoma: A technical note

Original paper

J Contemp Brachytherapy 2026; 18, 2: 204–211

DOI: https://doi.org/10.5114/jcb.2026.163317
Abstract View text (PDF)